LBS-008 RESEARCH AND DEVELOPMENT SERVICES AGREEMENTResearch and Development Services Agreement • April 5th, 2022 • Belite Bio, Inc • Pharmaceutical preparations
Contract Type FiledApril 5th, 2022 Company IndustryThis Research and Development Services Agreement (this “Agreement”), effective as of July 1, 2021 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).
LBS-008 RESEARCH AND DEVELOPMENT SERVICES AGREEMENTResearch and Development Services Agreement • January 21st, 2022 • Belite Bio, Inc • Pharmaceutical preparations
Contract Type FiledJanuary 21st, 2022 Company IndustryThis Research and Development Services Agreement (this “Agreement”), effective as of July 1, 2021 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).